$19.95
-0.10 | -0.50%
-0.10 | -0.50%
Today's Range:
19.76 -
20.14
SGEN Avg. Daily Volume:
1,155,000
05/30/12 - 2:30 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 20.05 |
| 52 Week High | 22.40 |
| 52 Week Low | 12.29 |
| Avg. Daily Vol. (Mil) | 1.14 |
| Beta (3 year) | 1.20 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,346.88 |
| Shares Out (Mil) | 117.05 |
| Float (Mil) | 54.30 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.90 |
| Current Ratio | 5.20 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 17.94 |
| Price/Book | 10.66 |
| Price/Cash Flow | -20.40 |
| Per Share Data | |
| Earnings | -1.14 |
| Sales | 1.12 |
| Book Value | 1.88 |
| Cash Flow | -0.98 |
| Business Summary | |
|---|---|
| Seattle Genetics, Inc. is a biotechnology company, which is focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. | |
| General Information | |
| 21823 30th Drive South East
Bothell, WA 98021 |
|
| www.seagen.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 483 | |
| CEO: Dr. Clay B. Siegall,PhD | |
| Short Interest | |
| Current Month (Mil) | 31.39 |
| Previous Month (Mil) | 30.99 |
| Short Interest Ratio (Days) | 26.20 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -31.90 |
| Return on Investments | -59.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,439.31 | 1,315.57 | 2,843.45 | 16.31 |
Oil *
103.32
|
|
DOWN
141.38 |
DOWN
16.85 |
DOWN
27.54 |
DOWN
1.00 |
10 Yr
1.63%
SPDR Gold
152.34
|
|
-1.12%
|
-1.26%
|
-0.96%
|
-5.78%
|
Data delayed 20 minutes |
Connect with TheStreet